These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12217354)

  • 1. Efficient liquid-phase synthesis of 2'-hydroxychalcones.
    Stoyanov EV; Champavier Y; Simon A; Basly JP
    Bioorg Med Chem Lett; 2002 Oct; 12(19):2685-7. PubMed ID: 12217354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and evaluation of novel boronic-chalcone derivatives as antitumor agents.
    Kumar SK; Hager E; Pettit C; Gurulingappa H; Davidson NE; Khan SR
    J Med Chem; 2003 Jul; 46(14):2813-5. PubMed ID: 12825923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linked parallel synthesis and MTT bioassay screening of substituted chalcones.
    Lawrence NJ; Rennison D; McGown AT; Ducki S; Gul LA; Hadfield JA; Khan N
    J Comb Chem; 2001; 3(5):421-6. PubMed ID: 11549359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor agents. Part 202: novel 2'-amino chalcones: design, synthesis and biological evaluation.
    Xia Y; Yang ZY; Xia P; Bastow KF; Nakanishi Y; Lee KH
    Bioorg Med Chem Lett; 2000 Apr; 10(8):699-701. PubMed ID: 10782667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological evaluation of indolizine-chalcone hybrids as new anticancer agents.
    Park S; Kim EH; Kim J; Kim SH; Kim I
    Eur J Med Chem; 2018 Jan; 144():435-443. PubMed ID: 29288944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of chalcones and their derived pyrazoles as potential cytotoxic agents.
    Bhat BA; Dhar KL; Puri SC; Saxena AK; Shanmugavel M; Qazi GN
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3177-80. PubMed ID: 15893928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological activities of fluorinated chalcone derivatives.
    Nakamura C; Kawasaki N; Miyataka H; Jayachandran E; Kim IH; Kirk KL; Taguchi T; Takeuchi Y; Hori H; Satoh T
    Bioorg Med Chem; 2002 Mar; 10(3):699-706. PubMed ID: 11814858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chalcones: a new class of antimitotic agents.
    Edwards ML; Stemerick DM; Sunkara PS
    J Med Chem; 1990 Jul; 33(7):1948-54. PubMed ID: 2362275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and anti-proliferative activity of fluoro-substituted chalcones.
    Burmaoglu S; Algul O; Anıl DA; Gobek A; Duran GG; Ersan RH; Duran N
    Bioorg Med Chem Lett; 2016 Jul; 26(13):3172-3176. PubMed ID: 27217001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of alpha-substitutions on structure and biological activity of anticancer chalcones.
    Lawrence NJ; Patterson RP; Ooi LL; Cook D; Ducki S
    Bioorg Med Chem Lett; 2006 Nov; 16(22):5844-8. PubMed ID: 16949281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic 4'-aminochalcones and related compounds.
    Dimmock JR; Jha A; Zello GA; Allen TM; Santos CL; Balzarini J; De Clercq E; Manavathu EK; Stables JP
    Pharmazie; 2003 Apr; 58(4):227-32. PubMed ID: 12749401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-breast cancer activity of heteroaryl chalcone derivatives.
    Solomon VR; Lee H
    Biomed Pharmacother; 2012 Apr; 66(3):213-20. PubMed ID: 22440895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and cytotoxicity of 2,5-dihydroxychalcones and related compounds.
    Nam NH; Hong DH; You YJ; Kim Y; Bang SC; Kim HM; Ahn BZ
    Arch Pharm Res; 2004 Jun; 27(6):581-8. PubMed ID: 15283456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chalcone derivatives targeting mitosis: synthesis, evaluation of antitumor activity and lipophilicity.
    Pinto P; Machado CM; Moreira J; Almeida JDP; Silva PMA; Henriques AC; Soares JX; Salvador JAR; Afonso C; Pinto M; Bousbaa H; Cidade H
    Eur J Med Chem; 2019 Dec; 184():111752. PubMed ID: 31610374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and anti-cancer activity evaluation of novel prenylated and geranylated chalcone natural products and their analogs.
    Wang HM; Zhang L; Liu J; Yang ZL; Zhao HY; Yang Y; Shen D; Lu K; Fan ZC; Yao QW; Zhang YM; Teng YO; Peng Y
    Eur J Med Chem; 2015 Mar; 92():439-48. PubMed ID: 25590864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid-phase synthesis of new pyrrolobenzodiazepine-chalcone conjugates: DNA-binding affinity and anticancer activity.
    Kamal A; Shankaraiah N; Prabhakar S; Reddy ChR; Markandeya N; Reddy KL; Devaiah V
    Bioorg Med Chem Lett; 2008 Apr; 18(7):2434-9. PubMed ID: 18325766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of a series of novel bichalcones linked with a 1,4-dimethylenepiperazine moiety and examination of their cytotoxicity.
    Reddy MV; Chen SS; Lin ML; Chan HH; Kuo PC; Wu TS
    Chem Pharm Bull (Tokyo); 2011; 59(12):1549-54. PubMed ID: 22130379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solid-phase synthesis of 2'-hydroxychalcones. Effects on cell growth inhibition, cell cycle and apoptosis of human tumor cell lines.
    Neves MP; Cravo S; Lima RT; Vasconcelos MH; Nascimento MS; Silva AM; Pinto M; Cidade H; Corrêa AG
    Bioorg Med Chem; 2012 Jan; 20(1):25-33. PubMed ID: 22177409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and evaluation of modified chalcone based p53 stabilizing agents.
    Iftikhar S; Khan S; Bilal A; Manzoor S; Abdullah M; Emwas AH; Sioud S; Gao X; Chotana GA; Faisal A; Saleem RSZ
    Bioorg Med Chem Lett; 2017 Sep; 27(17):4101-4106. PubMed ID: 28743509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and multi-step synthesis of chalcone-polyamine conjugates as potent antiproliferative agents.
    Rioux B; Pouget C; Fidanzi-Dugas C; Gamond A; Laurent A; Semaan J; Pinon A; Champavier Y; Léger DY; Liagre B; Duroux JL; Fagnère C; Sol V
    Bioorg Med Chem Lett; 2017 Sep; 27(18):4354-4357. PubMed ID: 28838697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.